Author

Pan Tao

Huazhong Agricultural UniversityORCID 0000-0002-0082-2229Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Venigalla Basaveswara RaoiD· 2 shared Ashok K. ChopraiD· 1 shared Emily K. HendrixiD· 1 shared Erchao Sun· 1 shared Guoqi Li· 1 shared Haiguang Song· 1 shared Himanshu BatraiD· 1 shared Jessica A. PlanteiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Venigalla Basaveswara RaoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Periplasmic gatekeeping of phage DNA entry by rSAM enzyme-mediated maturation of an effector with His-X-Ser repeats

Mengling Li, Erchao Sun, Shuangshuang Wang, Yuxuan Huang, Haiguang Song, Sirong Kuang, Guoqi Li, Y. G. Liu, Ziwei Xia, Xueqi Zhang, Jiumin Han, Zhaoxu Dong, Venigalla Basaveswara Rao, Lvhui Sun, Pan Tao

This study identifies a bacterial antiphage system, HXS, that targets phage DNA entry through rSAM enzyme-mediated maturation of an effector with His-X-Ser repeats.

bioRxiv · Jan 6, 2026 · PreprintMicrobiology

A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines

Jingen Zhu, Jian Sha, Himanshu Batra, Swati Jain, Xiaorong Wu, Emily K. Hendrix, Paul B. Kilgore, Keer Sun, Kenneth S. Plante, Jessica A. Plante, Jordyn L. Walker, Pan Tao, Ashok K. Chopra, Venigalla Basaveswara Rao

This paper describes a bacteriophage T4-based nanoparticle platform for designing dual COVID-19-Flu mucosal vaccines, showing robust immune responses and protection in mice.

Small Science · Jan 28, 2025Peer-reviewedMicrobiology